Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab294Source: DataRank Database

Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients is a research paper published in Open Forum Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.64)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Amanda Howard,Matthew A. Miller ORCID,Lorna L Allen,Misha Huang,Kyle C. Molina ORCID

Live enrichment

PubMed:34262988 PMC:PMC8274359 OpenAlex:https://openalex.org/W3173055383

Colorado Clinical and Translational Science Institute

Grant: UL1 RR025780

National Institutes of Health

Grant: 3UL1RR025780-02S2

Colorado Clinical and Translational Science Institute (UL1)

NIH

National Center for Research Resources

FWCI

0.64

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://academic.oup.com/ofid/article-pdf/8/7/ofab294/38917326/ofab294.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/8/7/ofab294/38917326/ofab294.pdf

journalhttps://doi.org/10.1093/ofid/ofab294

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34262988

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8274359

Fields of Study

Clostridium difficile and Clostridium perfringens researchNosocomial Infections in ICUHelicobacter pylori-related gastroenterology studies03 medical and health sciences0302 clinical medicine

Keywords

MedicineClostridioidesIncidence (geometry)Odds ratioInternal medicineConfidence intervalCohortRetrospective cohort studyFidaxomicinSurgeryVancomycinCDITransplant RecipientBezlotoxumabClostridioides Difficile InfectionMajor Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being